Starling Medical Valuation Estimate
Starling Medical Valuation as of Last Funding Round
Starling Medical Company Overview
Starling Medical uses artificial intelligence and mechanical innovation to develop a tech-enabled urinary catheter for patients with neurogenic bladder dysfunction. It helps replace urinary catheter use for severe neurogenic bladder patients. The company's diagnostic devices and software infrastructure seamlessly integrate into anyone's bathroom routine for enhanced freedom and independence. Starling won the 2021 Texas A&M New Ventures Competition. Starling Medical has raised $4.24 million over five rounds from investors, including Rebel Fund, Coho Deeptech, and Centauri Fun.
Starling Medical Valuation History
New to Pre-IPO Investing?
Get smarter about private markets and Pre-IPO investing:
- Get key practice tips for private-market investing
- Understand how to evaluate deal terms and common structures
- Evaluate fees and their impact on returns
- Develop a thesis and underwrite your investment
- Learn common pitfalls first-time investors face
FAQ
Does Starling Medical have stock?
Yes, Starling Medical and almost all privately held companies issue stock so founders, employees, and investors can participate in equity ownership. However, because Starling Medical is privately held, it is more challenging to acquire shares than if the company was publicly traded.
Is Starling Medical publicly traded?
No, Starling Medical is a privately held company. It is not publicly traded or offered directly on any stock exchange like the NYSE, Nasdaq, etc.
Who owns Starling Medical stock?
As a privately held company, Starling Medical shares are held by its founders, management, employees, venture
capital funds, or other private individuals and institutional investors.
Disclosure rules differ for private and public companies, so it may not always be possible to know the
complete ownership (cap table) of a private company like Starling Medical.
What is the stock symbol for Starling Medical?
Starling Medical is a privately held company. Therefore, it does not have a stock symbol or “ticker” that trades on public exchanges like the NYSE, Nasdaq, etc.
Can I buy Starling Medical shares on UpMarket?
If you would like to buy shares in Starling Medical, please provide your information in the form at the top of this page and click the button titled
“I want to buy this stock.”
One of our investor relations team members will contact you to discuss Starling Medical stock availability.
Note: inquiries are non-binding, subject to market availability, and shares may only be purchased by accredited investors that meet all
eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance,
Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including,
Starling Medical as well.
What is Starling Medical stock price?
The stock price of Starling Medical can be calculated by taking the valuation of the company divided by the
number of shares outstanding. Because a private company can issue new shares at any time, we do not know the
current number of shares outstanding.
For illustrative purposes, however, assuming Starling Medical has issued 250 million shares, at the estimated
UpMarket valuation of $17.92 million, each share of Starling Medical stock
would be worth $0.07.
How do Starling Medical pre-IPO trades work?
Pre-IPO trades for Starling Medical will typically involve accredited investors purchasing shares from current
shareholders through specialized investment platforms like UpMarket. Trades generally occur on the secondary market, meaning Starling Medical doesn't
issue new shares or receive capital–shares are privately exchanged between two parties.
While investors aim to profit from a potential IPO or acquisition, these investments carry high risks due to
limited liquidity and information. Understanding all terms and conditions is crucial, as each transaction can
have unique characteristics. Investing in private companies can be extremely risky and may result in
significant capital loss.
When is Starling Medical going to go public?
The decision to go public through an Initial Public Offering (IPO) is complex and depends on various factors,
including the company's financial performance, market conditions, and strategic goals.
Unless Starling Medical officially announces its intention to go public, any predictions about when or if it
will do so would be speculative.
Investors interested in Starling Medical should monitor official company communications and reliable financial
news sources for any updates regarding potential IPO plans.
How do I exit my investment if I invest in Starling Medical with UpMarket?
Exiting your investment in Starling Medical typically involves one of these scenarios: 1) selling your shares
on a secondary market to other interested investors; 2) holding shares until a liquidity event occurs, such as
the company going public (IPO) or being acquired.
Investors must know that the timing and availability of these exit options are inherently unpredictable, and
there is no guarantee of when or if they will occur.
How can I sell Starling Medical shares?
If you own Starling Medical shares, you may be able to find a buyer on a pre-IPO marketplace or via an introduction by a registered broker-dealer like UpMarket. It is important to note that the class of shares you own may impact your ability to sell. For example, shares issued to startup employees often have transaction limitations, including lock-up periods and a right of first refusal by the company, which may prevent you from selling your shares freely.
How does UpMarket estimate the valuation of Starling Medical?
UpMarket’s valuation estimate for Starling Medical is algorithmically generated based on recent primary round
financings by Starling Medical, market conditions, company popularity, sector performance, and public market
comps.
It is important to note that UpMarket’s valuation estimate for Starling Medical could be outdated, may not
reflect all recent news or market events, and is not intended to inform any investment decision-making.
UpMarket’s valuation estimate is not meant to be a warranty or projection of potential financial returns or
company performance. Valuations can change rapidly and unexpectedly.
Why choose UpMarket?
Founded in 2019, UpMarket has brokered over $1.3 billion in alternative investments for more than 1300+
investors, including principal invested and appreciation as of March 31, 2026. These investments span pre-IPO
companies, hedge funds, private equity, real estate, and other alternative assets. Approximately $301 million
is managed by UpMarket Management, with the remainder managed by affiliates. Past performance is not
predictive of future results. UpMarket is a licensed broker-dealer based in the United States.
If you are an accredited investor, you can create a
free account to access our deal flow and
opportunities. There is never any pressure to invest.
UpMarket clients have invested in companies like
Starling Medical,
Anduril, Perplexity, Neuralink, and many others. UpMarket and its leadership have been mentioned in media
outlets like Forbes,
WealthManagement,
Wealth
and Finance News, and TechBullion.
Starling Medical Management
| Name | Position |
|---|---|
| Hannah McKenney | CEO |
